GenusPlus Group stock has drifted lower over the past week and quarter, yet the latest earnings present a very different story. The contractor closed at A$8.92 today while reporting about A$1.28b of revenue for FY 2026 and record underlying EBITDA just above A$100m. That short term share price softness sits alongside a company that has more than doubled its revenue base in two years and now carries a A$2.2b order book.
For investors, the real question is how that rapid scale up and margin profile will develop over the next several years.
Love the revenue growth and record EBITDA from GenusPlus Group but concerned about how many contractors can balance rapid scale with stable margins over time? Check out the list of solid balance sheet and fundamentals stocks (20 results).
Prefer clear visuals instead of scrolling through dense earnings tables for GenusPlus Group? Get a full picture of how the business is scaling with an at a glance view of its revenue and profit trends in the company report for GenusPlus Group.
The bullish story around GenusPlus Group is that grid renewal and energy transition work can drive multi year growth with better quality, more recurring earnings. The FY 2026 numbers go a long way to backing that up. Revenue reached A$1.28b and underlying EBITDA passed A$100m, which management called a step change. That scale up was not just one off construction. The company now points to A$764m of recurring revenue and a A$2.2b order book, concrete markers for the long term work thesis.
Another key claim is that acquisitions can widen capability and support margin quality rather than dilute it. The completion of MPK and progress on Railtrain and MGC integrations, alongside a year of record EBITDA, shows GenusPlus Group absorbing much larger projects while keeping earnings moving in the right direction, even as the reported net margin sits in the mid single digits.
Compare GenusPlus Group's big order book and recurring revenue story with what the street is pricing in. See the consensus price target analysis for GenusPlus Group to check how analyst targets stack up against the latest A$8.92 share price.The core bearish concern on GenusPlus Group is that rapid contract wins and acquisitions create lumpy earnings with fragile margins and higher execution risk. The FY 2026 print partly supports that. Net profit margin slipped to 3.8% from 4.7% even with revenue at A$1.28b and record underlying EBITDA above A$100m. That suggests scale is not yet flowing cleanly through to the bottom line.
Bears also question integration and earnings quality. MPK only closed recently and Railtrain and MGC are still bedding down, so the year does not yet demonstrate that acquired work can sustain margins across a full cycle. The A$2.2b order book and A$764m of recurring revenue address some fears about workload visibility, but the recent 90 day share price fall of 11.2% indicates the market is still pricing in concern about contract execution and guidance risk.
With GenusPlus Group carrying a premium 37x P/E and a thinner 3.8% net margin, the real stress test is on the balance sheet. Check whether cash, debt and covenants actually support this growth path in the financial health analysis of GenusPlus Group stock.If GenusPlus Group's rapid scale up, record FY 2026 EBITDA and 37x P/E have your attention, register for free with Simply Wall St and add it to a Watchlist to track price against fair value and wait for a setup that fits your plan. Once you own the stock, keep your decisions focused with the Portfolio Command Center that cuts through noise and flags the updates that matter most to your holdings. For a broader view, use the Community to see how other investors are thinking about opportunities and risks across the market. By spotting potential catalysts and pressure points early, you give yourself a better chance to stay ahead of market moves.
New ideas move first. Markets reward investors who spot quiet breakout potential, rising momentum and stocks dropping into value ranges before the crowd. Scan these fresh lists and act now.
This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.
Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team@simplywallst.com